These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8184873)

  • 1. Perioperative administration of a single dose of conjugated oestrogen to uraemic patients is ineffective in improving haemostasis.
    Jacobs P; Jacobson J; Kahn D
    Am J Hematol; 1994 May; 46(1):24-8. PubMed ID: 8184873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of uraemic bleeding with conjugated oestrogen.
    Liu YK; Kosfeld RE; Marcum SG
    Lancet; 1984 Oct; 2(8408):887-90. PubMed ID: 6148618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia.
    Viganò G; Gaspari F; Locatelli M; Pusineri F; Bonati M; Remuzzi G
    Kidney Int; 1988 Dec; 34(6):853-8. PubMed ID: 2850395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of platelet glycoprotein Ib in uraemia.
    Sloand EM; Sloand JA; Prodouz K; Klein HG; Yu MW; Harvath L; Fricke W
    Br J Haematol; 1991 Mar; 77(3):375-81. PubMed ID: 2012763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate doses of aspirin and risk of bleeding in renal failure.
    Livio M; Benigni A; Viganò G; Mecca G; Remuzzi G
    Lancet; 1986 Feb; 1(8478):414-6. PubMed ID: 2868341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic and fibrinolytic response to desmopressin in uremic patients.
    Chen KS; Huang CC; Leu ML; Deng P; Lo SK
    Blood Purif; 1997; 15(2):84-91. PubMed ID: 9087815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions.
    Fernandez F; Goudable C; Sie P; Ton-That H; Durand D; Suc JM; Boneu B
    Br J Haematol; 1985 Jan; 59(1):139-48. PubMed ID: 3918557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated estrogens for the management of bleeding associated with renal failure.
    Livio M; Mannucci PM; Viganò G; Mingardi G; Lombardi R; Mecca G; Remuzzi G
    N Engl J Med; 1986 Sep; 315(12):731-5. PubMed ID: 3018561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nimesulide versus placebo on hemostasis in healthy volunteers.
    Marbet GA; Yasikoff Strub ML; Macciocchi A; Tsakiris DA
    Eur J Clin Pharmacol; 1998 Jul; 54(5):383-7. PubMed ID: 9754980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation.
    Gordge MP; Leaker B; Patel A; Oviasu E; Cameron JS; Neild GH
    Thromb Res; 1990 Jan; 57(2):171-82. PubMed ID: 2315882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 14. Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients.
    Castaman G; Rodeghiero F; Lattuada A; La Greca G; Mannucci PM
    Am J Hematol; 1993 Dec; 44(4):266-9. PubMed ID: 8237998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII complex in uraemia and effects of haemodialysis.
    Turney JH; Woods HF; Fewell MR; Weston MJ
    Br Med J (Clin Res Ed); 1981 May; 282(6277):1653-6. PubMed ID: 6786417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia].
    Mazerska M; Pawlak K; Azzadin A; Małyszko J; Małyszko J; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1992 Oct; 88(4):230-7. PubMed ID: 1488323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
    Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
    Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet disorders in uraemia before and after haemodialysis under the influence of low dose aspirin.
    Tschugguel W; Blaicher A; Kramer L; Felfernig M; Jüngling G; Kurz M; Gnant M; Zimpfer M
    Thromb Res; 1995 Nov; 80(3):225-33. PubMed ID: 8578549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.